Silence Therapeutics plc
SLN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21 | -$27 | -$22 | $23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $3 |
| Change in WC | $5 | -$5 | $7 | -$26 |
| Other Non-Cash | $2 | $8 | $0 | -$25 |
| Operating Cash Flow | -$11 | -$22 | -$12 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$2 | -$70 | -$21 |
| Inv. Sales/Matur. | $0 | $1 | $0 | $91 |
| Other Inv. Act. | $51 | $0 | $26 | -$2 |
| Investing Cash Flow | $51 | -$2 | -$44 | $68 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$18 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $38 |
| Financing Cash Flow | $0 | $0 | $0 | $20 |
| Forex Effect | -$0 | $0 | $0 | $7 |
| Net Chg. in Cash | $40 | -$23 | -$56 | $59 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42 | $65 | $121 | $83 |
| End Cash | $82 | $42 | $65 | $121 |
| Free Cash Flow | -$11 | -$22 | -$12 | -$25 |